证券记录 · 已归档季度
ARDX
Ardelyx, Inc. · Healthcare · Biotechnology
18被追踪持有人
+1Δ持有人
90.83M持有股份
$500.46M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +5.9% ·
股份流向 -2.7% ·
净新建仓位 +5.6%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 22.74K | $74,350 | n/a | n/a |
| Q2 2026 | 96 | 0 | 123.12M | $629.22M | +7 | −8 |
| Q1 2026 | 100 | +3 | 138.17M | $826.25M | +6 | −3 |
| Q4 2025 | 95 | +1 | 146.57M | $854.46M | +1 | n/a |
| Q3 2025 | 18 | +1 | 90.83M | $500.46M | +1 | n/a |
| Q2 2025 | 14 | -2 | 85.87M | $336.62M | n/a | −2 |
| Q1 2025 | 13 | +1 | 41.26M | $202.59M | +2 | −1 |
| Q4 2024 | 12 | +2 | 28.08M | $142.38M | +3 | −1 |
| Q3 2024 | 9 | 0 | 14.54M | $100.22M | n/a | n/a |
| Q2 2024 | 9 | n/a | 13.39M | $99.20M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 20.82M | +0.4% | $114.74M | 0.0% | ▲ Add | 2 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (被动) | 18.37M | +14.6% | $101.21M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 9.72M | -1.2% | $53.55M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Marshall Wace ✦ | 8.94M | -20.5% | $49.28M | 0.1% | ▼ Trim | 4 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 7.64M | -34.5% | $42.11M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 5.76M | +1.6% | $31.72M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 3.31M | +34.8% | $18.25M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 2.89M | n/a | $15.90M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | Goldman Sachs Group ✦ | 2.58M | n/a | $14.24M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 2.49M | +23.2% | $13.72M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 2.14M | -7.3% | $11.81M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 12 | JPMorgan Chase ✦ | 2.01M | n/a | $11.06M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 13 | Renaissance Technologies ✦ | 1.69M | +29.9% | $9.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 1.53M | -30.9% | $8.42M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 579.02K | 新增 | $3.19M | 0.0% | New | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 227.32K | +9.7% | $1.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | Wellington Management ✦ | 102.57K | +5.1% | $565,139 | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 18 | Fidelity (FMR) ✦ | 21.39K | -64.1% | $117,864 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $3.19M | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 235 持有人, 168.96M 股份, $997.54M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 21
RAAB MICHAEL
Officer, Director · 15.01K 股 · $57,888
Aug 21
RAAB MICHAEL
Officer, Director · 15.98K 股 · $61,618
Aug 21
RAAB MICHAEL
Officer, Director · 8.41K 股 · $32,440
Aug 21
RAAB MICHAEL
Officer, Director · 19.18K 股 · $73,968
Aug 21
Hohenleitner Susan
Officer · 1.56K 股 · $6,009
Aug 21
Williams Laura A
Officer · 3.49K 股 · $13,445
Aug 21
Williams Laura A
Officer · 3.09K 股 · $11,914
Aug 21
Williams Laura A
Officer · 2.43K 股 · $9,372
Aug 21
Williams Laura A
Officer · 1.73K 股 · $6,688
Aug 21
Kelliher Mike
Officer · 3.10K 股 · $11,972
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G: Rubric Capital Management LP
Aug 11
SC 13G/A: INTEGRATED CORE STRATEGIES (US) LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据